Sodium pyruvate
SIAL/P8574 - BioXtra, ≥99%
Synonym: α-Ketopropionic acid sodium salt; 2-Oxopropanoic acid sodium salt; Pyruvic acid sodium salt
CAS Number: 113-24-6
Empirical Formula (Hill Notation): C3H3NaO3
Molecular Weight: 110.04
EC Number: 204-024-4
MDL Number: MFCD00002586
Linear Formula: CH3COCOONa
Product Type: Chemical
anion traces | chloride (Cl-): ≤0.05% |
sulfate (SO42-): ≤0.05% | |
assay | ≥99% |
cation traces | Al: ≤0.0005% |
Ca: ≤0.001% | |
Cu: ≤0.0005% | |
Fe: ≤0.0005% | |
K: ≤0.005% | |
Mg: ≤0.0005% | |
NH4+: ≤0.05% | |
Pb: ≤0.001% | |
Zn: ≤0.0005% | |
form | powder |
impurities | ≤0.005% Phosphorus (P) |
≤0.1% Insoluble matter | |
InChI | 1S/C3H4O3.Na/c1-2(4)3(5)6 |
InChI key | DAEPDZWVDSPTHF-UHFFFAOYSA |
mp | >300 °C (lit.) |
product line | BioXtra |
Quality Level | 200 |
SMILES string | [Na+].CC(=O)C([O-])=O |
solubility | H2O: 1 M, clear, colorless |
storage temp. | 2-8°C |
Application: | Sodium pyruvate has been used as a component: • of cutting solution for rat brain tissue slice preparation • of M-199 medium for the maturation of oocytes • of Krebs-Henseleit buffer for plasma incubation |
Biochem/physiol Actions: | Sodium pyruvate based therapeutic regimen is effective for treating mitochondrial diseases. It decreases tissue damage associated with the pathophysiology of brain damage, haemorrhagic shock and ischemia-reperfusion injury models. |
Packaging: | 5, 25, 100 g in poly bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H317 - H319 |
Precautionary statements | P280 - P302 + P352 - P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 1 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥99% |
mp | >300 °C (lit.) |
Storage Temp. | 2-8°C |
UNSPSC | 12352207 |